Alert FDA Approves New Type 2 Diabetes Drug Bexagliflozin Another SGLT2 inhibitor has been approved for type 2 diabetes based on results from 23 clinical trials that included 5000 patients and more ...
Incidence patterns of STEMI and NSTEMI in type 1 diabetes depend on age, vascular history, and kidney function, a Finnish ...
Gum disease is more common in individuals with microvascular complications of diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) ...
Gum disease is more common in individuals with microvascular complications of diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) ...
Certain diabetes complications were linked to moderate and severe periodontitis, a cross-sectional analysis using Danish population-based data suggested. Among nearly 16,000 patients with type 2 ...
Microvascular disease affects the small blood vessels, particularly in the kidneys and eyes, and is a common diabetic complication. Diabetic nephropathy causes the deterioration of kidney function and ...
Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data. (HealthDay News) — Fourteen-day continuous glucose monitoring (CGM) traces added to ...
The association of diabetes with vision loss is well-known, but a new review suggests that individuals with type 2 diabetes (T2D) also face a significant risk for hearing loss. Hearing loss in T2D ...
Diabetic retinopathy and diabetic kidney disease are frequent microvascular complications of diabetes, both related to exacerbated vascular permeability coming from microvascular barrier ...
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) shows that low muscle mass is associated with a two-fold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results